TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs35705950
log Bayes Factor = 14.2818
Chromosome 11   position 1,241,221  (GRCh37) Explore rs35705950 on Ensembl!
Variant rs35705950 is listed in the   GWAS Catalog   ⇪
Variant rs35705950 is part of Cluster X0302

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
J84.1 Other interstitial pulmonary diseases with fibrosis
1.000 0.000 0.000
J84 Other interstitial pulmonary diseases
1.000 0.000 0.000
J84.9 Interstitial pulmonary disease, unspecified
1.000 0.000 0.000
J80-J84 Other respiratory diseases principally affecting the interstitium
0.954 0.046 0.000
Chapter X Diseases of the respiratory system
0.868 0.132 0.000
J80 Adult respiratory distress syndrome
0.855 0.145 0.000
J09-J18 Influenza and pneumonia
0.838 0.162 0.000
J60-J70 Lung diseases due to external agents
0.820 0.180 0.000
J18 Pneumonia, organism unspecified
0.816 0.184 0.000
J18.9 Pneumonia, unspecified
0.810 0.190 0.000
J95-J99 Other diseases of the respiratory system
0.766 0.234 0.000
J61 Pneumoconiosis due to asbestos and other mineral fibres
0.764 0.236 0.000
J14 Pneumonia due to Haemophilus influenzae
0.758 0.242 0.000
J84.8 Other specified interstitial pulmonary diseases
0.756 0.244 0.000
J20-J22 Other acute lower respiratory infections
0.751 0.249 0.000
J40-J47 Chronic lower respiratory diseases
0.739 0.261 0.000
J43 Emphysema
0.723 0.277 0.000
J81 Pulmonary oedema
0.717 0.283 0.000
J84.0 Alveolar and parietoalveolar conditions
0.717 0.283 0.000
J43.9 Emphysema, unspecified
0.711 0.289 0.000
J95 Postprocedural respiratory disorders, not elsewhere classified
0.685 0.315 0.000
J20 Acute bronchitis
0.679 0.321 0.000
J60 Coalworker's pneumoconiosis
0.657 0.343 0.000
J64 Unspecified pneumoconiosis
0.650 0.350 0.000
J15 Bacterial pneumonia, not elsewhere classified
0.642 0.358 0.000
J98 Other respiratory disorders
0.635 0.365 0.000
J82 Pulmonary eosinophilia, not elsewhere classified
0.630 0.369 0.000
J20.9 Acute bronchitis, unspecified
0.628 0.372 0.000
J10 Influenza due to identified influenza virus
0.622 0.378 0.000
J16 Pneumonia due to other infectious organisms, not elsewhere classified
0.601 0.399 0.000
J09 Influenza due to certain identified influenza virus
0.601 0.399 0.000
J47 Bronchiectasis
0.599 0.401 0.000
J12 Viral pneumonia, not elsewhere classified
0.593 0.407 0.000
J67 Hypersensitivity pneumonitis due to organic dust
0.588 0.412 0.000
J70 Respiratory conditions due to other external agents
0.588 0.412 0.000
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours
0.588 0.412 0.000
J66 Airway disease due to specific organic dust
0.588 0.412 0.000
J63 Pneumoconiosis due to other inorganic dusts
0.588 0.412 0.000
J62 Pneumoconiosis due to dust containing silica
0.588 0.412 0.000
J65 Pneumoconiosis associated with tuberculosis
0.588 0.412 0.000
J18.8 Other pneumonia, organism unspecified
0.585 0.415 0.000
J18.2 Hypostatic pneumonia, unspecified
0.585 0.415 0.000
J85-J86 Suppurative and necrotic conditions of lower respiratory tract
0.582 0.418 0.000
J21 Acute bronchiolitis
0.580 0.420 0.000
J95.0 Tracheostomy malfunction
0.573 0.427 0.000
J18.0 Bronchopneumonia, unspecified
0.558 0.442 0.000
J95.8 Other postprocedural respiratory disorders
0.556 0.444 0.000
J96 Respiratory failure, not elsewhere classified
0.549 0.451 0.000
J69 Pneumonitis due to solids and liquids
0.549 0.451 0.000
J43.2 Centrilobular emphysema
0.541 0.459 0.000
J15.1 Pneumonia due to Pseudomonas
0.541 0.459 0.000
J17 Pneumonia in diseases classified elsewhere
0.539 0.460 0.000
J45 Asthma
0.538 0.462 0.000
J95.9 Postprocedural respiratory disorder, unspecified
0.534 0.466 0.000
J41 Simple and mucopurulent chronic bronchitis
0.530 0.470 0.000
J98.8 Other specified respiratory disorders
0.529 0.471 0.000
J98.0 Diseases of bronchus, not elsewhere classified
0.519 0.481 0.000
J43.8 Other emphysema
0.518 0.481 0.000
J43.1 Panlobular emphysema
0.518 0.481 0.000
J43.0 MacLeod's syndrome
0.518 0.481 0.000
J11 Influenza, virus not identified
0.513 0.487 0.000
J98.6 Disorders of diaphragm
0.506 0.494 0.000
J45.0 Predominantly allergic asthma
0.497 0.503 0.000
J15.2 Pneumonia due to staphylococcus
0.492 0.508 0.000
J95.5 Postprocedural subglottic stenosis
0.491 0.509 0.000
J95.4 Mendelson's syndrome
0.491 0.509 0.000
J95.3 Chronic pulmonary insufficiency following surgery
0.491 0.509 0.000
J95.2 Acute pulmonary insufficiency following nonthoracic surgery
0.491 0.509 0.000
J95.1 Acute pulmonary insufficiency following thoracic surgery
0.491 0.509 0.000
J20.7 Acute bronchitis due to echovirus
0.486 0.513 0.000
J20.6 Acute bronchitis due to rhinovirus
0.486 0.513 0.000
J20.5 Acute bronchitis due to respiratory syncytial virus
0.486 0.513 0.000
J20.4 Acute bronchitis due to parainfluenza virus
0.486 0.513 0.000
J20.3 Acute bronchitis due to coxsackie virus
0.486 0.513 0.000
J20.2 Acute bronchitis due to streptococcus
0.486 0.513 0.000
J20.1 Acute bronchitis due to Haemophilus influenzae
0.486 0.513 0.000
J20.0 Acute bronchitis due to Mycoplasma pneumoniae
0.486 0.513 0.000
J20.8 Acute bronchitis due to other specified organisms
0.482 0.518 0.000
J15.4 Pneumonia due to other streptococci
0.478 0.522 0.000
J98.9 Respiratory disorder, unspecified
0.470 0.530 0.000
J10.1 Influenza with other respiratory manifestations, influenza virus identified
0.466 0.533 0.000
J15.8 Other bacterial pneumonia
0.461 0.539 0.000
J15.6 Pneumonia due to other aerobic Gram-negative bacteria
0.461 0.539 0.000
J15.5 Pneumonia due to Escherichia coli
0.461 0.539 0.000
J15.3 Pneumonia due to streptococcus, group B
0.461 0.539 0.000
J98.5 Diseases of mediastinum, not elsewhere classified
0.460 0.540 0.000
J21.9 Acute bronchiolitis, unspecified
0.457 0.543 0.000
J15.9 Bacterial pneumonia, unspecified
0.456 0.543 0.000
J98.3 Compensatory emphysema
0.455 0.545 0.000
J98.2 Interstitial emphysema
0.455 0.545 0.000
J69.8 Pneumonitis due to other solids and liquids
0.448 0.552 0.000
J10.8 Influenza with other manifestations, influenza virus identified
0.446 0.554 0.000
J10.0 Influenza with pneumonia, influenza virus identified
0.446 0.554 0.000
J22 Unspecified acute lower respiratory infection
0.445 0.555 0.000
J40 Bronchitis, not specified as acute or chronic
0.444 0.556 0.000
J99 Respiratory disorders in diseases classified elsewhere
0.442 0.558 0.000
J98.4 Other disorders of lung
0.438 0.562 0.000
J16.8 Pneumonia due to other specified infectious organisms
0.431 0.569 0.000
J16.0 Chlamydial pneumonia
0.431 0.569 0.000
J85 Abscess of lung and mediastinum
0.431 0.569 0.000
J15.7 Pneumonia due to Mycoplasma pneumoniae
0.429 0.571 0.000
J12.8 Other viral pneumonia
0.425 0.575 0.000
J12.3 Human metapneumovirus pneumonia
0.425 0.575 0.000
J12.2 Parainfluenza virus pneumonia
0.425 0.575 0.000
J12.1 Respiratory syncytial virus pneumonia
0.425 0.575 0.000
J12.0 Adenoviral pneumonia
0.425 0.575 0.000
J67.9 Hypersensitivity pneumonitis due to unspecified organic dust
0.422 0.578 0.000
J67.8 Hypersensitivity pneumonitis due to other organic dusts
0.422 0.578 0.000
J67.7 Air-conditioner and humidifier lung
0.422 0.578 0.000
J67.6 Maple-bark-stripper's lung
0.422 0.578 0.000
J67.5 Mushroom-worker's lung
0.422 0.578 0.000
J67.4 Maltworker's lung
0.422 0.578 0.000
J67.3 Suberosis
0.422 0.578 0.000
J67.2 Bird fancier's lung
0.422 0.578 0.000
J67.1 Bagassosis
0.422 0.578 0.000
J67.0 Farmer's lung
0.422 0.578 0.000
J62.8 Pneumoconiosis due to other dust containing silica
0.422 0.578 0.000
J62.0 Pneumoconiosis due to talc dust
0.422 0.578 0.000
J63.8 Pneumoconiosis due to other specified inorganic dusts
0.422 0.578 0.000
J63.5 Stannosis
0.422 0.578 0.000
J63.4 Siderosis
0.422 0.578 0.000
J63.3 Graphite fibrosis (of lung)
0.422 0.578 0.000
J63.2 Berylliosis
0.422 0.578 0.000
J63.1 Bauxite fibrosis (of lung)
0.422 0.578 0.000
J63.0 Aluminosis (of lung)
0.422 0.578 0.000
J66.8 Airway disease due to other specific organic dusts
0.422 0.578 0.000
J66.2 Cannabinosis
0.422 0.578 0.000
J66.1 Flax-dresser's disease
0.422 0.578 0.000
J66.0 Byssinosis
0.422 0.578 0.000
J68.9 Unspecified respiratory condition due to chemicals, gases, fumes and vapours
0.422 0.578 0.000
J68.8 Other respiratory conditions due to chemicals, gases, fumes and vapours
0.422 0.578 0.000
J68.4 Chronic respiratory conditions due to chemicals, gases, fumes and vapours
0.422 0.578 0.000
J68.3 Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours
0.422 0.578 0.000
J68.2 Upper respiratory inflammation due to chemicals, gases, fumes and vapours, not elsewhere classified
0.422 0.578 0.000
J68.1 Acute pulmonary oedema due to chemicals, gases, fumes and vapours
0.422 0.578 0.000
J68.0 Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours
0.422 0.578 0.000
J70.9 Respiratory conditions due to unspecified external agent
0.422 0.578 0.000
J70.8 Respiratory conditions due to other specified external agents
0.422 0.578 0.000
J70.4 Drug-induced interstitial lung disorder, unspecified
0.422 0.578 0.000
J70.3 Chronic drug-induced interstitial lung disorders
0.422 0.578 0.000
J70.2 Acute drug-induced interstitial lung disorders
0.422 0.578 0.000
J70.1 Chronic and other pulmonary manifestations due to radiation
0.422 0.578 0.000
J70.0 Acute pulmonary manifestations due to radiation
0.422 0.578 0.000
J12.9 Viral pneumonia, unspecified
0.417 0.583 0.000
J21.8 Acute bronchiolitis due to other specified organisms
0.416 0.584 0.000
J21.1 Acute bronchiolitis due to human metapneumovirus
0.416 0.584 0.000
J21.0 Acute bronchiolitis due to respiratory syncytial virus
0.416 0.584 0.000
J46 Status asthmaticus
0.397 0.603 0.000
J17.3 Pneumonia in parasitic diseases
0.397 0.603 0.000
J96.9 Respiratory failure, unspecified
0.394 0.606 0.000
J96.1 Chronic respiratory failure
0.394 0.606 0.000
J96.0 Acute respiratory failure
0.394 0.606 0.000
J69.1 Pneumonitis due to oils and essences
0.393 0.606 0.000
J42 Unspecified chronic bronchitis
0.388 0.612 0.000
J17.8 Pneumonia in other diseases classified elsewhere
0.387 0.613 0.000
J17.1 Pneumonia in viral diseases classified elsewhere
0.387 0.613 0.000
J45.8 Mixed asthma
0.386 0.614 0.000
J45.1 Nonallergic asthma
0.386 0.614 0.000
J41.8 Mixed simple and mucopurulent chronic bronchitis
0.380 0.620 0.000
J41.1 Mucopurulent chronic bronchitis
0.380 0.620 0.000
J41.0 Simple chronic bronchitis
0.380 0.620 0.000
J17.2 Pneumonia in mycoses
0.377 0.623 0.000
J11.8 Influenza with other manifestations, virus not identified
0.368 0.632 0.000
J11.0 Influenza with pneumonia, virus not identified
0.368 0.632 0.000
J15.0 Pneumonia due to Klebsiella pneumoniae
0.363 0.637 0.000
J86 Pyothorax
0.358 0.642 0.000
J13 Pneumonia due to Streptococcus pneumoniae
0.340 0.659 0.000
J99.0 Rheumatoid lung disease
0.333 0.666 0.000
J18.1 Lobar pneumonia, unspecified
0.330 0.670 0.000
J17.0 Pneumonia in bacterial diseases classified elsewhere
0.323 0.676 0.000
J85.2 Abscess of lung without pneumonia
0.323 0.677 0.000
J85.3 Abscess of mediastinum
0.309 0.691 0.000
J85.1 Abscess of lung with pneumonia
0.309 0.691 0.000
J85.0 Gangrene and necrosis of lung
0.309 0.691 0.000
J90-J94 Other diseases of pleura
0.298 0.702 0.000
J96.09 Acute respiratory failure; Type unspecified
0.282 0.717 0.000
J96.01 Acute respiratory failure; Type II [hypercapnic]
0.282 0.717 0.000
J96.00 Acute respiratory failure; Type I [hypoxic]
0.282 0.717 0.000
J96.19 Chronic respiratory failure; Type unspecified
0.282 0.717 0.000
J96.11 Chronic respiratory failure; Type II [hypercapnic]
0.282 0.717 0.000
J96.10 Chronic respiratory failure; Type I [hypoxic]
0.282 0.717 0.000
J96.99 Respiratory failure, unspecified; Type unspecified
0.282 0.717 0.000
J96.91 Respiratory failure unspecified; Type II [hypercapnic]
0.282 0.717 0.000
J96.90 Respiratory failure, unspecified; Type I [hypoxic]
0.282 0.717 0.000
J11.1 Influenza with other respiratory manifestations, virus not identified
0.280 0.720 0.000
J98.1 Pulmonary collapse
0.279 0.721 0.000
J99.8 Respiratory disorders in other diseases classified elsewhere
0.275 0.725 0.000
J44 Other chronic obstructive pulmonary disease
0.271 0.729 0.000
J92 Pleural plaque
0.270 0.730 0.000
J86.0 Pyothorax with fistula
0.254 0.746 0.000
J69.0 Pneumonitis due to food and vomit
0.248 0.751 0.000
J92.9 Pleural plaque without asbestos
0.244 0.756 0.000
J99.1 Respiratory disorders in other diffuse connective tissue disorders
0.242 0.758 0.001
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection
0.234 0.766 0.000
J92.0 Pleural plaque with presence of asbestos
0.210 0.790 0.000
J86.9 Pyothorax without fistula
0.201 0.799 0.000
J94 Other pleural conditions
0.150 0.850 0.000
J00-J06 Acute upper respiratory infections
0.146 0.853 0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.145 0.855 0.000
J93 Pneumothorax
0.130 0.870 0.000
J91 Pleural effusion in conditions classified elsewhere
0.129 0.871 0.000
J90 Pleural effusion, not elsewhere classified
0.128 0.872 0.000
J44.8 Other specified chronic obstructive pulmonary disease
0.120 0.880 0.000
J05 Acute obstructive laryngitis [croup] and epiglottitis
0.108 0.892 0.000
J94.9 Pleural condition, unspecified
0.107 0.892 0.000
J94.1 Fibrothorax
0.107 0.892 0.000
J94.0 Chylous effusion
0.107 0.892 0.000
J04 Acute laryngitis and tracheitis
0.106 0.893 0.000
J93.0 Spontaneous tension pneumothorax
0.106 0.894 0.000
J03 Acute tonsillitis
0.094 0.906 0.000
J94.2 Haemothorax
0.091 0.908 0.000
J01 Acute sinusitis
0.086 0.914 0.000
J04.1 Acute tracheitis
0.083 0.916 0.000
J05.1 Acute epiglottitis
0.081 0.919 0.000
J05.0 Acute obstructive laryngitis [croup]
0.078 0.922 0.000
J93.9 Pneumothorax, unspecified
0.077 0.923 0.000
J04.2 Acute laryngotracheitis
0.076 0.923 0.000
J93.8 Other pneumothorax
0.075 0.924 0.000
J94.8 Other specified pleural conditions
0.072 0.927 0.001
J06 Acute upper respiratory infections of multiple and unspecified sites
0.072 0.928 0.000
J02 Acute pharyngitis
0.070 0.930 0.000
J04.0 Acute laryngitis
0.069 0.931 0.000
J03.8 Acute tonsillitis due to other specified organisms
0.067 0.932 0.000
J03.0 Streptococcal tonsillitis
0.067 0.932 0.000
J01.8 Other acute sinusitis
0.062 0.938 0.000
J01.4 Acute pansinusitis
0.062 0.938 0.000
J01.3 Acute sphenoidal sinusitis
0.062 0.938 0.000
J01.2 Acute ethmoidal sinusitis
0.062 0.938 0.000
J01.1 Acute frontal sinusitis
0.062 0.938 0.000
J01.0 Acute maxillary sinusitis
0.062 0.938 0.000
J44.9 Chronic obstructive pulmonary disease, unspecified
0.059 0.941 0.000
J03.9 Acute tonsillitis, unspecified
0.056 0.944 0.000
J00 Acute nasopharyngitis [common cold]
0.053 0.947 0.000
J06.8 Other acute upper respiratory infections of multiple sites
0.052 0.948 0.000
J06.0 Acute laryngopharyngitis
0.052 0.948 0.000
J02.8 Acute pharyngitis due to other specified organisms
0.050 0.949 0.000
J02.0 Streptococcal pharyngitis
0.050 0.949 0.000
J01.9 Acute sinusitis, unspecified
0.043 0.957 0.001
J93.1 Other spontaneous pneumothorax
0.042 0.957 0.001
K01.1 Impacted teeth
0.000 0.959 0.041
I35.1 Aortic (valve) insufficiency
0.031 0.969 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.977 0.023
T39.1 4-Aminophenol derivatives
0.000 0.977 0.023
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.979 0.021
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.979 0.021
N87.9 Dysplasia of cervix uteri, unspecified
0.021 0.979 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.980 0.020
K01 Embedded and impacted teeth
0.000 0.980 0.020
J06.9 Acute upper respiratory infection, unspecified
0.018 0.982 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.982 0.017
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.983 0.017
T39.0 Salicylates
0.000 0.984 0.016
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.984 0.016
T43.2 Other and unspecified antidepressants
0.000 0.984 0.016
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.984 0.016
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.984 0.016
T39.4 Antirheumatics, not elsewhere classified
0.000 0.984 0.016
T39.2 Pyrazolone derivatives
0.000 0.984 0.016
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.984 0.015
T43.9 Psychotropic drug, unspecified
0.000 0.984 0.015
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.984 0.015
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.984 0.015
J02.9 Acute pharyngitis, unspecified
0.015 0.985 0.000
K01.0 Embedded teeth
0.000 0.985 0.015
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.985 0.015
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.985 0.015
T36 Poisoning by systemic antibiotics
0.000 0.985 0.015
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.985 0.015
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.985 0.015
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.986 0.014
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.986 0.014
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.986 0.014
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.986 0.014
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.986 0.014
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.986 0.014
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.987 0.013
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.987 0.013
T46.1 Calcium-channel blockers
0.000 0.987 0.013
T43.6 Psychostimulants with abuse potential
0.000 0.988 0.012
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.988 0.012
T45.5 Anticoagulants
0.000 0.988 0.012
H57.9 Disorder of eye and adnexa, unspecified
0.012 0.988 0.000
T36.0 Penicillins
0.000 0.988 0.012
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.988 0.011
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.988 0.011
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.988 0.011
T46.7 Peripheral vasodilators
0.000 0.988 0.011
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.988 0.011
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.988 0.011
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.988 0.011
T45.0 Antiallergic and antiemetic drugs
0.000 0.989 0.011
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.989 0.011
T40.6 Other and unspecified narcotics
0.000 0.989 0.011
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.989 0.011
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.989 0.011
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.989 0.011
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.989 0.011
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.989 0.011
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.989 0.011
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.989 0.011
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.989 0.011
T44.0 Anticholinesterase agents
0.000 0.989 0.011
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.989 0.011
T45.8 Other primarily systemic and haematological agents
0.000 0.989 0.011
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.989 0.011
T45.6 Fibrinolysis-affecting drugs
0.000 0.989 0.011
T45.4 Iron and its compounds
0.000 0.989 0.011
T45.3 Enzymes, not elsewhere classified
0.000 0.989 0.011
T45.2 Vitamins, not elsewhere classified
0.000 0.989 0.011
T36.9 Systemic antibiotic, unspecified
0.000 0.989 0.011
T36.8 Other systemic antibiotics
0.000 0.989 0.011
T36.7 Antifungal antibiotics, systemically used
0.000 0.989 0.011
T36.6 Rifamycins
0.000 0.989 0.011
T36.5 Aminoglycosides
0.000 0.989 0.011
T36.4 Tetracyclines
0.000 0.989 0.011
T36.3 Macrolides
0.000 0.989 0.011
T36.2 Chloramphenicol group
0.000 0.989 0.011
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.989 0.011
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.989 0.011
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.989 0.011
T47.7 Emetics
0.000 0.989 0.011
T47.6 Antidiarrhoeal drugs
0.000 0.989 0.011
T47.5 Digestants
0.000 0.989 0.011
T47.4 Other laxatives
0.000 0.989 0.011
T47.3 Saline and osmotic laxatives
0.000 0.989 0.011
T47.2 Stimulant laxatives
0.000 0.989 0.011
T47.0 Histamine H(2)-receptor antagonists
0.000 0.989 0.011
T50.8 Diagnostic agents
0.000 0.989 0.011
T50.7 Analeptics and opioid receptor antagonists
0.000 0.989 0.011
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.989 0.011
T50.5 Appetite depressants
0.000 0.989 0.011
T50.4 Drugs affecting uric acid metabolism
0.000 0.989 0.011
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.989 0.011
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.989 0.011
T50.1 Loop [high-ceiling] diuretics
0.000 0.989 0.011
T50.0 Mineralocorticoids and their antagonists
0.000 0.989 0.011
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.989 0.011
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.989 0.011
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.989 0.010
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.989 0.010
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.989 0.010
T37.5 Antiviral drugs
0.000 0.989 0.010
T37.4 Anthelminthics
0.000 0.989 0.010
T37.3 Other antiprotozoal drugs
0.000 0.989 0.010
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.989 0.010
T37.1 Antimycobacterial drugs
0.000 0.989 0.010
T37.0 Sulphonamides
0.000 0.989 0.010
T41.5 Therapeutic gases
0.000 0.989 0.010
T41.4 Anaesthetic, unspecified
0.000 0.989 0.010
T41.3 Local anaesthetics
0.000 0.989 0.010
T41.2 Other and unspecified general anaesthetics
0.000 0.989 0.010
T41.1 Intravenous anaesthetics
0.000 0.989 0.010
T41.0 Inhaled anaesthetics
0.000 0.989 0.010
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.989 0.010
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.989 0.010
T48.5 Anti-common-cold drugs
0.000 0.989 0.010
T48.4 Expectorants
0.000 0.989 0.010
T48.3 Antitussives
0.000 0.989 0.010
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.989 0.010
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.989 0.010
T48.0 Oxytocic drugs
0.000 0.989 0.010
T49.9 Topical agent, unspecified
0.000 0.989 0.010
T49.8 Other topical agents
0.000 0.989 0.010
T49.7 Dental drugs, topically applied
0.000 0.989 0.010
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.989 0.010
T49.5 Ophthalmological drugs and preparations
0.000 0.989 0.010
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.989 0.010
T49.3 Emollients, demulcents and protectants
0.000 0.989 0.010
T49.2 Local astringents and local detergents
0.000 0.989 0.010
T49.1 Antipruritics
0.000 0.989 0.010
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.989 0.010
H57 Other disorders of eye and adnexa
0.011 0.989 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.990 0.010
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.990 0.010
T40.8 Lysergide [LSD]
0.000 0.990 0.010
T40.7 Cannabis (derivatives)
0.000 0.990 0.010
T40.5 Cocaine
0.000 0.990 0.010
T40.3 Methadone
0.000 0.990 0.010
T40.1 Heroin
0.000 0.990 0.010
T40.0 Opium
0.000 0.990 0.010
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.990 0.010
H57.0 Anomalies of pupillary function
0.010 0.990 0.000
T38.9 Other and unspecified hormone antagonists
0.000 0.990 0.010
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.990 0.010
T38.7 Androgens and anabolic congeners
0.000 0.990 0.010
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.990 0.010
T38.5 Other oestrogens and progestogens
0.000 0.990 0.010
T38.4 Oral contraceptives
0.000 0.990 0.010
T38.2 Antithyroid drugs
0.000 0.990 0.010
T38.0 Glucocorticoids and synthetic analogues
0.000 0.990 0.010
T40.4 Other synthetic narcotics
0.000 0.991 0.009
Z57.3 Occupational exposure to other air contaminants
0.009 0.991 0.000
T40.2 Other opioids
0.000 0.991 0.008
H57.1 Ocular pain
0.008 0.992 0.000
Z57 Occupational exposure to risk-factors
0.008 0.992 0.000
T38.1 Thyroid hormones and substitutes
0.000 0.992 0.008
G93.3 Postviral fatigue syndrome
0.000 0.992 0.008
R91 Abnormal findings on diagnostic imaging of lung
0.008 0.992 0.000
G93 Other disorders of brain
0.000 0.992 0.008
Z57.2 Occupational exposure to dust
0.008 0.992 0.000
H57.8 Other specified disorders of eye and adnexa
0.008 0.992 0.000
T42.1 Iminostilbenes
0.000 0.992 0.007
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.993 0.007
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.993 0.007
T42.3 Barbiturates
0.000 0.993 0.007
T42.2 Succinimides and oxazolidinediones
0.000 0.993 0.007
G93.9 Disorder of brain, unspecified
0.000 0.993 0.007
T42.0 Hydantoin derivatives
0.000 0.993 0.007
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.993 0.007
M43.16 Spondylolisthesis (Lumbar region)
0.000 0.993 0.007
G93.6 Cerebral oedema
0.000 0.993 0.007
G93.8 Other specified disorders of brain
0.000 0.993 0.007
S91.1 Open wound of toe(s) without damage to nail
0.007 0.993 0.000
H55-H59 Other disorders of eye and adnexa
0.006 0.994 0.000
M43.17 Spondylolisthesis (Lumbosacral region)
0.000 0.994 0.006
G93.1 Anoxic brain damage, not elsewhere classified
0.000 0.994 0.006
Z57.5 Occupational exposure to toxic agents in other industries
0.006 0.994 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.994 0.006
M43.1 Spondylolisthesis
0.000 0.994 0.006
K20 Oesophagitis
0.006 0.994 0.000
Z57.9 Occupational exposure to unspecified risk-factor
0.006 0.994 0.000
Z57.8 Occupational exposure to other risk-factors
0.006 0.994 0.000
Z57.7 Occupational exposure to vibration
0.006 0.994 0.000
Z57.6 Occupational exposure to extreme temperature
0.006 0.994 0.000
Z57.4 Occupational exposure to toxic agents in agriculture
0.006 0.994 0.000
Z57.1 Occupational exposure to radiation
0.006 0.994 0.000
Z57.0 Occupational exposure to noise
0.006 0.994 0.000
G93.4 Encephalopathy, unspecified
0.000 0.994 0.006
G93.2 Benign intracranial hypertension
0.000 0.994 0.006
G93.0 Cerebral cysts
0.000 0.994 0.006
G93.5 Compression of brain
0.000 0.994 0.006
M25.77 Osteophyte (Ankle and foot)
0.000 0.994 0.006
G93.7 Reye's syndrome
0.000 0.994 0.006
H55 Nystagmus and other irregular eye movements
0.006 0.994 0.000
G55.3 Nerve root and plexus compressions in other dorsopathies
0.000 0.994 0.006
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances
0.006 0.994 0.000
I35.2 Aortic (valve) stenosis with insufficiency
0.006 0.994 0.000
S91 Open wound of ankle and foot
0.006 0.994 0.000
I35 Nonrheumatic aortic valve disorders
0.006 0.994 0.000
T42.4 Benzodiazepines
0.000 0.994 0.006
S91.3 Open wound of other parts of foot
0.005 0.995 0.000
C16.9 Stomach, unspecified
0.005 0.995 0.000
F33.9 Recurrent depressive disorder, unspecified
0.000 0.995 0.005
Z60 Problems related to social environment
0.005 0.995 0.000
M43.19 Spondylolisthesis (Site unspecified)
0.000 0.995 0.005
Z63 Other problems related to primary support group, including family circumstances
0.005 0.995 0.000
S92.00 Fracture of calcaneus (closed)
0.005 0.995 0.000
G91.9 Hydrocephalus, unspecified
0.000 0.995 0.005
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified
0.005 0.995 0.000
H58 Other disorders of eye and adnexa in diseases classified elsewhere
0.005 0.995 0.000
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)
0.000 0.995 0.005
M43.15 Spondylolisthesis (Thoracolumbar region)
0.000 0.995 0.005
M43.14 Spondylolisthesis (Thoracic region)
0.000 0.995 0.005
M43.13 Spondylolisthesis (Cervicothoracic region)
0.000 0.995 0.005
M43.12 Spondylolisthesis (Cervical region)
0.000 0.995 0.005
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)
0.000 0.995 0.005
M43.10 Spondylolisthesis (Multiple sites in spine)
0.000 0.995 0.005
Z59 Problems related to housing and economic circumstances
0.005 0.995 0.000
Z64 Problems related to certain psychosocial circumstances
0.005 0.995 0.000
Z56 Problems related to employment and unemployment
0.005 0.995 0.000
S92.0 Fracture of calcaneus
0.005 0.995 0.000
Z63.7 Other stressful life events affecting family and household
0.004 0.995 0.000
Z60.2 Living alone
0.005 0.995 0.000
Z65 Problems related to other psychosocial circumstances
0.004 0.995 0.000
Z62 Other problems related to upbringing
0.004 0.995 0.000
Z61 Problems related to negative life events in childhood
0.004 0.995 0.000
Z55 Problems related to education and literacy
0.004 0.995 0.000
Z63.4 Disappearance and death of family member
0.004 0.996 0.000
Z58 Problems related to physical environment
0.004 0.996 0.000
S91.7 Multiple open wounds of ankle and foot
0.004 0.996 0.000
S91.2 Open wound of toe(s) with damage to nail
0.004 0.996 0.000
S91.0 Open wound of ankle
0.004 0.996 0.000
G91 Hydrocephalus
0.000 0.996 0.004
C16.0 Cardia
0.004 0.996 0.000
C16 Malignant neoplasm of stomach
0.004 0.996 0.000
S92 Fracture of foot, except ankle
0.004 0.996 0.000
M23.89 Other internal derangements of knee (Unspecified ligament or Unspecified meniscus)
0.000 0.996 0.004
S90-S99 Injuries to the ankle and foot
0.004 0.996 0.000
J30-J39 Other diseases of upper respiratory tract
0.004 0.996 0.000
Z60.9 Problem related to social environment, unspecified
0.004 0.996 0.000
Z60.8 Other problems related to social environment
0.004 0.996 0.000
Z60.5 Target of perceived adverse discrimination and persecution
0.004 0.996 0.000
Z60.4 Social exclusion and rejection
0.004 0.996 0.000
Z60.3 Acculturation difficulty
0.004 0.996 0.000
Z60.1 Atypical parenting situation
0.004 0.996 0.000
Z60.0 Problems of adjustment to life-cycle transitions
0.004 0.996 0.000
Z99.1 Dependence on respirator
0.004 0.996 0.000
Z63.9 Problem related to primary support group, unspecified
0.004 0.996 0.000
Z63.6 Dependent relative needing care at home
0.004 0.996 0.000
Z63.5 Disruption of family by separation and divorce
0.004 0.996 0.000
Z63.3 Absence of family member
0.004 0.996 0.000
Z63.2 Inadequate family support
0.004 0.996 0.000
Z63.1 Problems in relationship with parents and in-laws
0.004 0.996 0.000
Z59.0 Homelessness
0.004 0.996 0.000
Z56.6 Other physical and mental strain related to work
0.004 0.996 0.000
Z64.0 Problems related to unwanted pregnancy
0.004 0.996 0.000
H59.9 Postprocedural disorder of eye and adnexa, unspecified
0.004 0.996 0.000
H59.0 Vitreous syndrome following cataract surgery
0.004 0.996 0.000
H59.8 Other postprocedural disorders of eye and adnexa
0.004 0.996 0.000
C16.6 Greater curvature of stomach, unspecified
0.004 0.996 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.